• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇对癌细胞质膜微粘度和脂类组成的影响。

Effects of Paclitaxel on Plasma Membrane Microviscosity and Lipid Composition in Cancer Cells.

机构信息

Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Square, 10/1, 603005 Nizhny Novgorod, Russia.

N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Kosygin st. 4, 119991 Moscow, Russia.

出版信息

Int J Mol Sci. 2023 Jul 29;24(15):12186. doi: 10.3390/ijms241512186.

DOI:10.3390/ijms241512186
PMID:37569560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10419023/
Abstract

The cell membrane is an important regulator for the cytotoxicity of chemotherapeutic agents. However, the biochemical and biophysical effects that occur in the membrane under the action of chemotherapy drugs are not fully described. In the present study, changes in the microviscosity of membranes of living HeLa-Kyoto tumor cells were studied during chemotherapy with paclitaxel, a widely used antimicrotubule agent. To visualize the microviscosity of the membranes, fluorescence lifetime imaging microscopy (FLIM) with a BODIPY 2 fluorescent molecular rotor was used. The lipid profile of the membranes was assessed using time-of-flight secondary ion mass spectrometry ToF-SIMS. A significant, steady-state decrease in the microviscosity of membranes, both in cell monolayers and in tumor spheroids, was revealed after the treatment. Mass spectrometry showed an increase in the unsaturated fatty acid content in treated cell membranes, which may explain, at least partially, their low microviscosity. These results indicate the involvement of membrane microviscosity in the response of tumor cells to paclitaxel treatment.

摘要

细胞膜是化疗药物细胞毒性的重要调节剂。然而,化疗药物作用下膜中发生的生化和生物物理效应尚未得到充分描述。在本研究中,我们研究了广泛使用的抗微管药物紫杉醇化疗过程中活 HeLa-Kyoto 肿瘤细胞膜的微粘度变化。为了可视化膜的微粘度,我们使用带有 BODIPY 2 荧光分子转子的荧光寿命成像显微镜(FLIM)进行了研究。使用飞行时间二次离子质谱法(ToF-SIMS)评估了膜的脂质分布。结果显示,在单层细胞和肿瘤球体处理后,膜的微粘度均显著且稳定地降低。质谱分析显示,处理后的细胞膜中不饱和脂肪酸含量增加,这至少可以部分解释其低微粘度。这些结果表明,膜微粘度参与了肿瘤细胞对紫杉醇治疗的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfb/10419023/b2eec1bdadc1/ijms-24-12186-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfb/10419023/69c20b377b84/ijms-24-12186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfb/10419023/851aa6ee8b0c/ijms-24-12186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfb/10419023/8e1d81b35c6e/ijms-24-12186-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfb/10419023/b2eec1bdadc1/ijms-24-12186-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfb/10419023/69c20b377b84/ijms-24-12186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfb/10419023/851aa6ee8b0c/ijms-24-12186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfb/10419023/8e1d81b35c6e/ijms-24-12186-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfb/10419023/b2eec1bdadc1/ijms-24-12186-g004.jpg

相似文献

1
Effects of Paclitaxel on Plasma Membrane Microviscosity and Lipid Composition in Cancer Cells.紫杉醇对癌细胞质膜微粘度和脂类组成的影响。
Int J Mol Sci. 2023 Jul 29;24(15):12186. doi: 10.3390/ijms241512186.
2
Mapping cisplatin-induced viscosity alterations in cancer cells using molecular rotor and fluorescence lifetime imaging microscopy.利用分子转子和荧光寿命成像显微镜绘制顺铂诱导的癌细胞粘度变化图。
J Biomed Opt. 2020 Dec;25(12). doi: 10.1117/1.JBO.25.12.126004.
3
Correlation of Plasma Membrane Microviscosity and Cell Stiffness Revealed via Fluorescence-Lifetime Imaging and Atomic Force Microscopy.荧光寿命成像和原子力显微镜揭示质膜微粘度与细胞刚性的相关性。
Cells. 2023 Nov 6;12(21):2583. doi: 10.3390/cells12212583.
4
The Role of Plasma Membrane Viscosity in the Response and Resistance of Cancer Cells to Oxaliplatin.质膜粘度在癌细胞对奥沙利铂的反应和抗性中的作用
Cancers (Basel). 2021 Dec 7;13(24):6165. doi: 10.3390/cancers13246165.
5
Development of resistance to 5-fluorouracil affects membrane viscosity and lipid composition of cancer cells.对 5-氟尿嘧啶的耐药性发展会影响癌细胞的膜粘度和脂质组成。
Methods Appl Fluoresc. 2022 Aug 25;10(4). doi: 10.1088/2050-6120/ac89cd.
6
Photodynamic therapy with Photoditazine increases microviscosity of cancer cells membrane in cellulo and in vivo.光动力疗法用 Photoditazine 增加细胞膜的微粘度在细胞和体内的癌细胞。
J Photochem Photobiol B. 2024 Oct;259:113007. doi: 10.1016/j.jphotobiol.2024.113007. Epub 2024 Aug 8.
7
Changes in membrane microviscosity associated with phagocytosis: effects of colchicine.与吞噬作用相关的膜微粘度变化:秋水仙碱的作用
Proc Natl Acad Sci U S A. 1977 Mar;74(3):1072-6. doi: 10.1073/pnas.74.3.1072.
8
Direct investigation of viscosity of an atypical inner membrane of Bacillus spores: a molecular rotor/FLIM study.芽孢杆菌孢子非典型内膜粘度的直接研究:分子转子/荧光寿命成像研究
Biochim Biophys Acta. 2013 Nov;1828(11):2436-43. doi: 10.1016/j.bbamem.2013.06.028. Epub 2013 Jul 3.
9
Enveloped viruses as model membrane systems: microviscosity of vesicular stomatitis virus and host cell membranes.包膜病毒作为模型膜系统:水疱性口炎病毒和宿主细胞膜的微粘度
Biochemistry. 1976 Aug 10;15(16):3563-70. doi: 10.1021/bi00661a026.
10
Fluorescence lifetime imaging of molecular rotors in living cells.活细胞中分子转子的荧光寿命成像
J Vis Exp. 2012 Feb 9(60):2925. doi: 10.3791/2925.

本文引用的文献

1
Development of resistance to 5-fluorouracil affects membrane viscosity and lipid composition of cancer cells.对 5-氟尿嘧啶的耐药性发展会影响癌细胞的膜粘度和脂质组成。
Methods Appl Fluoresc. 2022 Aug 25;10(4). doi: 10.1088/2050-6120/ac89cd.
2
Interaction of Docetaxel with Phosphatidylcholine Membranes: A Combined Experimental and Computational Study.多西他赛与磷脂膜的相互作用:实验与计算研究的结合。
J Membr Biol. 2022 Jun;255(2-3):277-291. doi: 10.1007/s00232-022-00219-z. Epub 2022 Feb 17.
3
The Role of Plasma Membrane Viscosity in the Response and Resistance of Cancer Cells to Oxaliplatin.
质膜粘度在癌细胞对奥沙利铂的反应和抗性中的作用
Cancers (Basel). 2021 Dec 7;13(24):6165. doi: 10.3390/cancers13246165.
4
Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy.紫杉醇:在现代肿瘤学和基于纳米医学的癌症治疗中的应用。
Oxid Med Cell Longev. 2021 Oct 18;2021:3687700. doi: 10.1155/2021/3687700. eCollection 2021.
5
Cholesterol modulates the interaction between paclitaxel and Langmuir monolayers simulating cell membranes.胆固醇调节紫杉醇与模拟细胞膜的 Langmuir 单层之间的相互作用。
Colloids Surf B Biointerfaces. 2021 Sep;205:111889. doi: 10.1016/j.colsurfb.2021.111889. Epub 2021 May 31.
6
Mapping cisplatin-induced viscosity alterations in cancer cells using molecular rotor and fluorescence lifetime imaging microscopy.利用分子转子和荧光寿命成像显微镜绘制顺铂诱导的癌细胞粘度变化图。
J Biomed Opt. 2020 Dec;25(12). doi: 10.1117/1.JBO.25.12.126004.
7
New Insights Into Targeting Membrane Lipids for Cancer Therapy.靶向膜脂用于癌症治疗的新见解
Front Cell Dev Biol. 2020 Sep 2;8:571237. doi: 10.3389/fcell.2020.571237. eCollection 2020.
8
Role of Death Receptors-associated Lipid Rafts in Oxaliplatin-induced Death Mode Regulation of HepG2 Cells.死亡受体相关脂筏在奥沙利铂诱导 HepG2 细胞死亡模式调控中的作用。
Anticancer Res. 2020 May;40(5):2573-2582. doi: 10.21873/anticanres.14228.
9
Prediction of paclitaxel pharmacokinetic based on in vitro studies: Interaction with membrane models and human serum albumin.基于体外研究的紫杉醇药代动力学预测:与膜模型和人血清白蛋白的相互作用。
Int J Pharm. 2020 Apr 30;580:119222. doi: 10.1016/j.ijpharm.2020.119222. Epub 2020 Mar 17.
10
Cellular Interactome Dynamics during Paclitaxel Treatment.紫杉醇治疗期间的细胞相互作用组动态。
Cell Rep. 2019 Nov 19;29(8):2371-2383.e5. doi: 10.1016/j.celrep.2019.10.063.